Page 18 - Sohini Das

Tata Punch tops 2024 sales charts; ends Maruti Suzuki's 40-year reign

Three of the top five best-selling cars in 2024 were SUVs.

Weakening rupee may not be shot in the arm for India's pharma exporters

The rupee has been hovering above Rs 85 mark vis-a-vis the US dollar in the recent past

Auto sales shake off pandemic blues, hit record high of 26.1 mn units

Shailesh Chandra, managing director of Tata Motors Passenger Vehicles and Tata Passenger Electric Mobility, said the industry remains "optimistic" about PV growth in the new calendar year

Granules India focused on getting FDA nod for drug from Gagillapur by FY26

It had voluntarily paused production in September

Why is Tata Motors thirsting for competition despite losing EV market share

Chandra says when the market expands, one benefits from a wider portfolio, but when the market is not growing, products start cannibalising among themselves

Tata Motors' new EVs promise over 500 km range on a single charge

This has been made possible by declining global costs of battery cells for EVs

The India story: The journey to becoming the 'pharmacy of the world'

Critical tweaks in laws, spirit of enterprise and the pandemic brought about this transition. Tech and innovation will now define the industry's future

Action likely against AbbVie executive who signed self-declaration

Pharma cos and docs say medical conferences have declined since March after UCPMP was notified

Silver lining: How technology is changing the landscape of elder care

The concluding part of the silver economy series looks at innovative apps and wearables that are empowering seniors and their families

Renault-Nissan's Indian ties in question amid Honda-Nissan merger talks

Nissan Motor India declined to comment on the matter. Honda Cars India too did not comment

In growth lane: Exports of passenger vehicles, 2-wheelers surge in 2024

Over 14% of passenger vehicles and 16% of two-wheelers manufactured in the country were exported between January and November

Bajaj Auto's Chetak 35-Series exports may start within six months

More variants of the e-scooter, targeting delivery executives, likely soon

Auto OEMs likely to invest $323 billion by 2070 on EVs: CSI report

The report further projected that EVs could add $9.6 trillion in OEM revenues by 2070, with cars being the major contributor from 2030 onwards

Diagnostic demand rises in towns; organised players lead expansion plans

The Healthcare Federation of India reports that over 50 per cent of aspirational districts identified by NITI Aayog, which lack essential infrastructure, are served by diagnostic chains

Serum Institute ties up with Bavarian Nordic to manufacture Mpox vaccine

Bavarian Nordic will transfer the technology of the current manufacturing process to SII to enable supply for the Indian market, the company said in a statement on Monday

High dispatches, low retail sales may up passenger vehicle inventory

Dispatches log best Nov numbers with 4.1% growth, retail sales decline 14%

CDMO player OneSource expands GLP-1 drug-device capacity as demand soars

OneSource Specialty Pharma recently raised Rs 801 crore through equity issuance

Metropolis Healthcare adds Core strength to specialty cancer diagnostics

Buys 100% stake in Core Diagnostics through cash, stock for Rs 247 crore

Eli Lilly to launch its obesity drug at competitive price in India in 2025

Lilly's rival Danish firm Novo Nordisk is also working to bring its obesity drug Wegovy (Semaglutide) to India soon, and according to reports the company may launch Wegovy in 2026

We will grow Camso brand in other OHT segments, says CEAT MD & CEO

RPG Group company CEAT has entered into an agreement with Michelin to acquire the Camso brand's off-highway construction equipment bias tyres and tracks business